Winston Pharmaceuticals, Inc. (WPHM)

0.0000 -0.0900 (-100.00%) At close: 03:09PM EDT

Winston Pharmaceuticals, Inc.

100 North Fairway Drive
Suite 134
Vernon Hills, IL 60061
United States
847-362-8200
https://www.winstonlabs.com

Sector(s): 
Industry: 
Full Time Employees: 9

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. Joel E. Bernstein M.D.	Founder, CEO, President & Director	288.9k	N/A	1943
Mr. Barry R. Hollingsworth CPA, CFA	Chief Financial Officer	N/A	N/A	1965
Mr. David A. Henninger M.S., R.A.C.	Vice President of Operations	N/A	N/A	N/A

Amounts are as of December 31, 2009 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Winston Pharmaceuticals, Inc., a pharmaceutical company, discovers, develops, and commercializes therapeutics for pain management. It focuses on pain indications, such as episodic cluster headache, chronic migraine headache, neuropathic pain syndromes, osteo-and rheumatoid arthritis, and pain and inflammation in inflammatory bowel disease, as well as niche indications. Winston Pharmaceuticals, Inc. was formerly known as Winston Laboratories, Inc. and changed its name to Winston Pharmaceuticals, Inc. in November 2008. The company was incorporated in 1998 and is headquartered in Vernon Hills, Illinois.

Corporate Governance

Winston Pharmaceuticals, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.